Market icon

Will there be a variant that overtakes Omicron in the US by...?

Market icon

Will there be a variant that overtakes Omicron in the US by...?

$13,667 Vol.

Feb 15, 2022
Polymarket

$13,667 Vol.

Polymarket
Market icon

By February 15th?

$880 Vol.

No

Market icon

By March 15th?

$3,723 Vol.

No

Market icon

By April 19th?

$6,561 Vol.

No

Market icon

By May 17th?

$2,503 Vol.

No

This is a market on whether there will be a variant that overtakes the Omicron variant in the US by February 15, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before February 15, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on February 15, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by March 15, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before March 15, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on March 15, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by April 19, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before April 19, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on April 19, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by May 17, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before May 17, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on May 17, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.

This is a market on whether there will be a variant that overtakes the Omicron variant in the US by February 15, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before February 15, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on February 15, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by March 15, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before March 15, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on March 15, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by April 19, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before April 19, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on April 19, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.This is a market on whether there will be a variant that overtakes the Omicron variant in the US by May 17, 2022. The market will resolve to “Yes” if in the US, a variant has a higher proportion of cases than Omicron on any day after the inception of this market, January 10, 2022, and on or before May 17, 2022. Otherwise, the market will resolver to “No.” The resolution source will be the weekly CDC Nowcast reports on variant proportions: https://covid.cdc.gov/covid-data-tracker/#variant-proportions. The source will be checked daily at 8 PM ET to see if any of their reports within the market timeframe has a variant with higher % in the TOTAL column than Omicron. The final check will be on May 17, 2022, at 8 PM ET. If the link to the source changes, the new source will be used. If the source is unavailable for any of the checks, https://covariants.org/per-country will be used instead.

Méfiez-vous des liens externes.

Questions fréquentes

« Will there be a variant that overtakes Omicron in the US by...? » est un marché de prédiction sur Polymarket avec 4 résultats possibles où les traders achètent et vendent des parts selon ce qu'ils pensent qu'il se passera. Le résultat en tête actuel est « By February 15th? » à 0%, suivi de « By March 15th? » à 0%. Les prix reflètent des probabilités en temps réel de la communauté. Par exemple, une part cotée à 0¢ implique que le marché attribue collectivement une probabilité de 0% à ce résultat. Ces cotes changent en permanence. Les parts du résultat correct sont échangeables contre $1 chacune lors de la résolution du marché.

À ce jour, « Will there be a variant that overtakes Omicron in the US by...? » a généré $13.7K en volume total de trading depuis le lancement du marché le Jan 11, 2022. Ce niveau d'activité reflète un fort engagement de la communauté Polymarket et garantit que les cotes actuelles sont alimentées par un large bassin de participants. Vous pouvez suivre les mouvements de prix en direct et trader sur n'importe quel résultat directement sur cette page.

Pour trader sur « Will there be a variant that overtakes Omicron in the US by...? », parcourez les 4 résultats disponibles sur cette page. Chaque résultat affiche un prix actuel représentant la probabilité implicite du marché. Pour prendre position, sélectionnez le résultat que vous estimez le plus probable, choisissez « Oui » pour trader en sa faveur ou « Non » pour trader contre, entrez votre montant et cliquez sur « Trader ». Si votre résultat choisi est correct lors de la résolution, vos parts « Oui » rapportent $1 chacune. S'il est incorrect, elles rapportent $0. Vous pouvez également vendre vos parts avant la résolution.

C'est un marché très ouvert. Le leader actuel pour « Will there be a variant that overtakes Omicron in the US by...? » est « By February 15th? » à seulement 0%, avec « By March 15th? » juste derrière à 0%. Aucun résultat ne dominant clairement, les traders voient cela comme très incertain, ce qui peut présenter des opportunités de trading uniques. Ces cotes sont mises à jour en temps réel, alors ajoutez cette page à vos favoris.

Les règles de résolution de « Will there be a variant that overtakes Omicron in the US by...? » définissent exactement ce qui doit se produire pour que chaque résultat soit déclaré gagnant, y compris les sources de données officielles utilisées pour déterminer le résultat. Vous pouvez consulter les critères de résolution complets dans la section « Règles » sur cette page au-dessus des commentaires. Nous recommandons de lire attentivement les règles avant de trader, car elles précisent les conditions exactes, les cas particuliers et les sources.